RETRACTED: Targeted immunotherapy for HER2-low breast cancer with 17p loss is a research paper published in Science Translational Medicine (2021). On theSindex it has a DataRank of 0. It has been cited 34 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Cancer Institute
Grant: R01CA203737
National Cancer Institute
Grant: R21CA213535
National Cancer Institute
Grant: R01CA211861
National Institutes of Health
Grant: 1R01CA211861-01A1
The Germ Cell Gene TDRD1 As A Novel Prostate Cancer Biomarker
European Commission
Grant: 211861
valiDation of Radical Engine Architecture systeMs
National Institutes of Health
Grant: 5R01CA203737-09
Targeting HER2-low breast cancer with 17p loss
National Institutes of Health
Grant: 5R21CA213535-02
Engineering Antibody Drug Conjugates To Target P53-Defective Triple Negative Breast Cancer
FWCI
1.78
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals